// App-Quantinova.ai

: Directed Thrombolysis (CDT) for Intermediate and High Risk Pulmonary Embolism

Researchers

Presenter

  • A. Singh

Principal Investigators

  • O. Charran

  • J. Filopei

  • A. Shujaat

  • D. Pan

  • R. Lookstein

  • J. Salonia

  • J. M. Shapiro

  • A. Isath

  • D. Steiger

Medical Centers

  • Medicine, Mt Sinai St Luke's / Mt Sinai West, New York, New York, United States

  • Division of Pulmonary & Critical Care Medicine, Mount Sinai St Luke’s, Mount Sinai West, and Mount Sinai Beth Israel, New York, NY, United States,

  • Pharmacy, Mount Sinai Beth Israel, New York, NY, United States,

  • Division of Pulmonary & Critical Care Medicine, Mount Sinai St Luke’s, Mount Sinai West, and Mount Sinai Beth Israel, New York, NY, United States,

  • Pulmonary/Critical Care, Mount Sinai Beth Israel, New York, NY, United States.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved